November 26, 2013: American Pain Society Letter to FDA Commissioner Hamburg About IMMPACT and ACTTION
The President of the American Pain Society (APS), Roger Fillingim, PhD, has sent a letter on behalf of the APS Board of Directors to Commissioner Margaret Hamburg of the FDA. The letter expresses the society’s appreciation for the FDA’s support of IMMPACT and ACTTION, and emphasizes that "This type of initiative is critical for advancement of therapies to treat persistent pain conditions that afflict millions of Americans." The complete letter is available here.
News
ACTTION Guide to Clinical Trials of Pain Treatments
The ACTTION Guide to Clinical Trials of Pain Treatments consists of two supplements published in the journal Pain Reports that include a series of articles describing research designs and methods, study conduct, outcome measures, data analyses and interpretation, and reporting recommendations for clinical trials of acute and chronic pain treatments.
Part I includes 9 articles that can be found here, and Part II includes 6 articles that can be found here.